Private Asset Management Inc Abb Vie Inc. Transaction History

Private Asset Management Inc

$419 Million
Q3 2023

A detailed history of Private Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Private Asset Management Inc holds 4,315 shares of ABBV stock, worth $869,472. This represents 0.15% of its overall portfolio holdings.

Number of Shares

4,315

Previous 4,815 10.38%

Holding current value

$869,472

Previous $648,000 0.77%

% of portfolio

0.15%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 20, 2023	SELL	$133.59 - $154.65 $66,795 - $77,325	-500 Reduced 10.38%	4,315 $643,000
Q2 2023 Jul 05, 2023	SELL	$132.51 - $164.9 $89,576 - $111,472	-676 Reduced 12.31%	4,815 $648,000
Q1 2023 Apr 04, 2023	SELL	$144.61 - $166.54 $28,922 - $33,308	-200 Reduced 3.51%	5,491 $875,000
Q3 2022 Oct 04, 2022	SELL	$134.21 - $153.93 $134 - $153	-1 Reduced 0.02%	5,691 $764,000
Q2 2022 Jul 06, 2022	SELL	$137.62 - $174.96 $15,826 - $20,120	-115 Reduced 1.98%	5,692 $872,000
Q1 2022 Apr 04, 2022	SELL	$131.98 - $163.75 $126,172 - $156,545	-956 Reduced 14.14%	5,807 $941,000
Q4 2021 Jan 03, 2022	SELL	$107.43 - $135.93 $6,445 - $8,155	-60 Reduced 0.88%	6,763 $916,000
Q2 2021 Jul 06, 2021	SELL	$105.21 - $117.21 $42,084 - $46,884	-400 Reduced 5.54%	6,823 $769,000
Q1 2021 Apr 02, 2021	BUY	$102.3 - $112.62 $34,782 - $38,290	340 Added 4.94%	7,223 $782,000
Q4 2020 Jan 05, 2021	BUY	$80.49 - $108.67 $32,195 - $43,468	400 Added 6.17%	6,883 $738,000
Q3 2020 Oct 06, 2020	SELL	$85.91 - $100.83 $7,560 - $8,873	-88 Reduced 1.34%	6,483 $568,000
Q2 2020 Jul 06, 2020	SELL	$73.37 - $98.18 $146 - $196	-2 Reduced 0.03%	6,571 $645,000
Q1 2020 Apr 02, 2020	SELL	$64.5 - $97.79 $29,025 - $44,005	-450 Reduced 6.41%	6,573 $501,000
Q4 2019 Jan 03, 2020	SELL	$72.13 - $90.25 $159,623 - $199,723	-2,213 Reduced 23.96%	7,023 $622,000
Q2 2019 Jul 02, 2019	BUY	$65.7 - $83.98 $8,541 - $10,917	130 Added 1.43%	9,236 $672,000
Q1 2019 Apr 03, 2019	SELL	$77.14 - $90.79 $15,428 - $18,158	-200 Reduced 2.15%	9,106 $734,000
Q4 2018 Jan 08, 2019	SELL	$77.85 - $96.01 $7,784 - $9,601	-100 Reduced 1.06%	9,306 $858,000
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $99,566 - $117,809	-1,109 Reduced 10.55%	9,406 $871,000
Q2 2018 Jul 10, 2018	BUY	$89.78 - $106.23 $113,571 - $134,380	1,265 Added 13.68%	10,515 $995,000
Q1 2018 Apr 06, 2018	BUY	$92.01 - $123.21 $8,648 - $11,581	94 Added 1.03%	9,250 $876,000
Q4 2017 Jan 05, 2018	SELL	$89.56 - $98.21 $420,932 - $461,586	-4,700 Reduced 33.92%	9,156 $885,000
Q3 2017 Oct 04, 2017	BUY	$69.85 - $89.22 $881,856 - $1.13 Million	12,625 Added 1025.59%	13,856 $1.23 Million
Q3 2017 Oct 03, 2017	BUY	$69.85 - $89.22 $85,985 - $109,829	1,231	1,231 $1.23 Billion

Others Institutions Holding ABBV

# of Institutions

3,760

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $356B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Asset Management Inc with notifications on news.

Account

Private Asset Management Inc Abb Vie Inc. Transaction History